These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15779654)

  • 21. Treatment of carcinoma of the prostate in the 1990's.
    el-Mahdi AM; Kuban DA
    Compr Ther; 1992 Jun; 18(6):10-4. PubMed ID: 1511588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prostate cancer and care. Bibliography].
    Régent L
    Soins; 2007 Mar; (713):55. PubMed ID: 17419579
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urothelial prostatic and urethral carcinomas].
    Neuzillet Y
    Rev Prat; 2014 Dec; 64(10):1367-8. PubMed ID: 25665314
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and treatment of prostate cancer. Beyond the controversy over whether and whom to screen, the appropriate method of screening is also subject to debate.
    Loeb S; Catalona WJ
    Med Econ; 2008 Dec; 85(24):36-41. PubMed ID: 19209648
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
    Postma R; Schröder FH; van Leenders GJ; Hoedemaeker RF; Vis AN; Roobol MJ; van der Kwast TH
    Eur Urol; 2007 Jul; 52(1):89-97. PubMed ID: 17257742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposed update on substaging metastatic prostate cancer.
    Crawford ED; Connor T
    Urology; 2009 Jul; 74(1):237. PubMed ID: 19567307
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostatic cancer: diagnosis and prognosis.
    Karr JP; Slack NH; Murphy GP
    Compr Ther; 1980 Oct; 6(10):34-41. PubMed ID: 7449363
    [No Abstract]   [Full Text] [Related]  

  • 28. Multimodal therapy of prostatic cancer.
    Paulson DF
    Urology; 1981 Apr; 17(4 Suppl):53-6. PubMed ID: 7210394
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimal management of prostatic cancer.
    Albertsen P; Marshall F
    Geriatrics; 1982 Dec; 37(12):69-72, 77-9. PubMed ID: 7141229
    [No Abstract]   [Full Text] [Related]  

  • 30. The Scandinavian Prostatic Cancer Group.
    Høisaeter PA; Rasmussen F
    Scand J Clin Lab Invest Suppl; 1985; 179():7-11. PubMed ID: 2934797
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in prostate cancer research.
    Languino LR
    J Cell Biochem; 2004 Jan; 91(1):1-2. PubMed ID: 14689575
    [No Abstract]   [Full Text] [Related]  

  • 32. Current strategies in the treatment of metastatic hormone-refractory prostate cancer.
    Ghosn M; Kattan J; Younes F
    Tunis Med; 2005 Dec; 83 Suppl 12():74. PubMed ID: 16430073
    [No Abstract]   [Full Text] [Related]  

  • 33. Early detection the key to prostate cancer.
    Kirby R
    Practitioner; 2009 Feb; 253(1715):17-8, 21-2. PubMed ID: 19326658
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer: a comprehensive review.
    Pentyala SN; Lee J; Hsieh K; Waltzer WC; Trocchia A; Musacchia L; Rebecchi MJ; Khan SA
    Med Oncol; 2000 May; 17(2):85-105. PubMed ID: 10871814
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy for prostate cancer: small steps or leaps and bounds? No huzzahs just yet!
    Raghavan D
    Br J Cancer; 2004 Sep; 91(6):1003-4. PubMed ID: 15475939
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trends in the management of prostate cancer over the last 20 years].
    Mangin P; Cornu JN; Rouprêt M
    Prog Urol; 2007 Apr; 17(2 Suppl 1):282-4. PubMed ID: 17569270
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G
    BJU Int; 2006 Mar; 97(3):485-91. PubMed ID: 16469013
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prostatic cancers].
    Soulié M; Beuzeboc P; Cornud F; Eschwege P; Gaschignard N; Grosclaude P; Hennequin C; Maingon P; Molinié V; Mongiat-Artus P; Moreau JL; Paparel P; Péneau M; Peyromaure M; Ravery V; Rébillard X; Richaud P; Salomon L; Staerman F; Villers A
    Prog Urol; 2007 Nov; 17(6):1159-230. PubMed ID: 18153992
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
    Wesley D; Cox HF
    J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.